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Abstract
Background: Previously we verified the radioprotective effect of lidocaine on the function and ultrastructure of salivary
glands in rabbits. However, the underlying mechanism of lidocaine’s radioprotective effect is unknown. We hypothesized
that lidocaine, as a membrane stabilization agent, has a protective effect on intracellular neuroreceptor-mediated signaling
and hence can help preserve the secretory function of salivary glands during radiotherapy.
Methods and Materials: Rabbits were irradiated with or without pretreatment with lidocaine before receiving fractionated
radiation to a total dose of 35 Gy. Sialoscintigraphy and saliva total protein assay were performed before radiation and 1
week after the last radiation fraction. Isolated salivary gland acini were stimulated with either carbachol or adrenaline. Ca2+
influx in response to the stimulation with these agonists was measured using laser scanning confocal microscopy.
Results: The uptake of activity and the excretion fraction of the parotid glands were significantly reduced after radiation,
but lidocaine had a protective effect. Saliva total protein concentration was not altered after radiation. For isolated acini,
Ca2+ influx in response to stimulation with carbachol, but not adrenaline, was impaired after irradiation; lidocaine
pretreatment attenuated this effect.
Conclusions: Lidocaine has a radioprotective effect on the capacity of muscarinic agonist-induced water secretion in
irradiated salivary glands.
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Introduction
Salivary gland dysfunction is one of the major side effects of
radiotherapy in patients treated for head and neck cancer [1]. The
exact mechanism of radiation-induced salivary gland injury per se
remains elusive. Although radiation induced sterilization of
progenitor cells which prevents the replenishment of saliva-
producing cells is considered as the main cause for late-stage
effects [2,3], the mechanism of early-stage functional damage is
different [2,4]. Salivary acinar cells are well differentiated and
have a low mitotic index [2]. Previous studies found that after
radiation the saliva flow reduced rapidly [5,6]. Secretory activity of
salivary glands decreased to 50% of normal levels whereas less
than 3% of apoptosis activity was observed 3 days after radiation
[5] and that no significant cell loss was observed within 10 days
after radiation [7]. This rapid radiation induced changes is not
compatible with mitotic or apoptotic cell death and that an
alternative hypothesis of early-stage radiation damage to the
salivary glands is needed [4,7,8].
Recently, researchers demonstrated that receptor-effector signal
transduction of water secretion in salivary glands was impaired
after irradiation [4,7,9]. Coppes et al. [4] suggested that radiation
impairs the muscarinic acetylcholine agonist-induced activation of
protein kinase C-alpha, measured as its translocation to the plasma
membrane, leading to damage in the ability to mobilize calcium
from intracellular stores, which is the driving force for water
secretion. Accordingly, it was proposed that the plasma membrane
is the key site of early-stage radiation damage to the salivary glands
and that the damage of intracellular neuroreceptor-mediated
signaling contributes to secretion dysfunction [8]. This new
concept of the mechanism of radiation-induced salivary gland
injury leads to promising, novel possibilities for interference with
and prevention of this early-stage damage.
Prompted by a finding stabilizing the basolateral membrane
using prophylactic lidocaine reduced radiation-induced damage in
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cultured parotid acinar cells [10], we recently verified that
lidocaine was able to prevent radiation-induced damage to the
function and ultrastructure of salivary glands in vivo in rabbits
[1,11]. However, the pharmacological mechanism of lidocaine’s
radioprotective profile is still largely unknown. Therefore, we
hypothesized that lidocaine, as a membrane stabilization agent,
has a protective effect on intracellular neuroreceptor-mediated
signaling and hence can help preserve the secretory function of
salivary glands during radiotherapy. To test this hypothesis, we
investigated the salivary glands of control, irradiated/sham-
treated, and irradiated/lidocaine-pretreated rabbits by stimulation
with neurotransmitter agonists in isolated glandular acini and
evaluated the simultaneous functional impairment of related
salivary glands using sialoscintigraphy and saliva protein assay.
Materials and Methods
Animals and study design
The study was approved by the Department of Landscape,
Environment and Rural Areas, Kiel, Germany (permit number: V
312-72241.122-14) according to the current German law on the
protection of animals. Twenty-four adult Chinchilla Bastard
rabbits were randomized into unirradiated control, irradiated/
sham-treated, and irradiated/lidocaine-pretreated groups of 8
rabbits each. All in vivo procedures were performed with the rabbits
under general anesthesia induced using a combination of 3 mg/kg
(S)-ketamine hydrochloride and 0.1 mg/kg xylazine hydrochlo-
ride. In the irradiated/sham-treated and irradiated/lidocaine-
pretreated groups, rabbits underwent a first sialoscintigraphy and
then received one fraction of radiation each day for 7 days. For
each rabbit in the irradiated/lidocaine-pretreated group, lidocaine
hydrochloride (Xylocaine, 2%, 10 mg/kg) was slowly administered
into a marginal ear vein 10 minutes before each radiation fraction.
One week after the last radiation fraction, a second sialoscinti-
graphy was performed. Whole stimulated saliva was collected
during sialoscintigraphy for the saliva total protein assay. A biopsy
specimen (56565 mm3) was excised from the parotid tissue
immediately after the second sialoscintigraphy, and the acini were
isolated for neurotransmitter agonist stimulation.
Radiation
X-ray irradiation was performed as described previously [1,11],
using MEVATRON 74-Siemens teletherapy unit (photon energy)
operated at 10 MeV with a dose rate of 3 Gy/min. The output of
accelerator was 1 Gy=80 MU at source-to-skin distance of
98 cm. A single dose of 5 Gy was applied during each irradiation.
An axial beam was directed toward the head of the rabbit,
extending from the retroauricular region into the tip of the nose
(field size 7.5610 cm), thus including all potential localization of
salivary glands. [1,11]Fractions were administered for 7 days,
yielding a total dose of 35 Gy. The equivalent dose in 2-Gy
fractions (a/b=3 Gy for late damage) was 56 Gy. [12]Since an
equivalent dose in 2-Gy fractions of 50 Gy is associated with a
100% risk of relevant xerostomia (Tolerance Doses 100/5)[13],
our study design reflected a clinically relevant situation.
Sialoscintigraphy
Rabbits were injected intravenously with 100 MBq of pertech-
netate (99mTcO4) and then imaging was done immediately with a
triple-head gamma camera (Picker 3000XP, LEUHR collimator;
Philips). Twenty minutes after injection, saliva production was
stimulated by subcutaneous administration of 0.01 mg/kg carba-
chol (Sigma-Aldrich, Seelze, Germany), and then the secretory
phase was monitored for 25 minutes. The percentage of uptake of
the administered activity was calculated for the 10 to 19 minutes
and 36 to 45 minutes. The salivary ejection fraction was defined as
a percentage: maximum uptake (until the 20th minute)2remain-
ing activity (after 45 minutes)/maximum uptake of the gland.
Saliva total protein assay
Saliva collections were performed during scintigraphy. After
carbachol stimulation at the 20th minute of scintigraphy, saliva
was collected for 25 minutes, until the end of scintigraphy.
Immediately after collection, the saliva samples were stored at –
70uC. Saliva total protein concentration ( mg/L) was measured
using the enzyme-linked immunosorbent assay, performed as
recommended by the manufacturer (R&D Systems, Minneapolis,
MN).
Isolation of glandular acini
In contrast to fully isolated parotid acinar cells, individual intact
acini as secretory units were obtained to mimic in vivo secretion
activity. The procedure for isolating glandular acini was based on
modified lacrimal acini isolation protocols [14,15]. Briefly,
56565 mm3 of tissue were excised from the parotid gland and
immediately immersed in a culture medium that contained
Dulbecco’s modified Eagle medium/Ham’s F-12, L-glutamine,
5% fetal calf serum, and penicillin/streptomycin. After being cut
into pieces, the samples were immersed in a culture medium that
contained purified collagenase (Sigma-Aldrich, Seelze, Germany),
60 U/mL, and then incubated at 37uC with oxygen for 40
minutes with constant agitation (100 cycles/min). After incuba-
tion, moderate pipetting yielded isolated acini, which were then
washed twice by centrifugation (3000 rpm, 5 minutes) and
resuspended. An MTT assay was performed to evaluate the
vitality of the isolated acini.
Neurotransmitter agonist stimulation
Hundreds of acini could be isolated each time for every single
gland. Isolated acini were loaded with Fluo-4 AM (Invitrogen,
Paisley, UK) with a concentration of 4 mM in the culture medium
by incubation for 60 minutes at 37uC with oxygen. The acini and
culture medium were placed on the nonfluorescent coverslips
coated with Cell-Tak (BD Biosciences, San Jose, CA) [14]. For
every gland, the isolated acini were randomly placed on six
coverslips and stimulated with neurotransmitter agonists. The
acini on three of these coverslips were stimulated with 10 mM
carbachol, and the acini on the other three were stimulated with
10 mM adrenaline (Sigma).
A laser scanning confocal microscope (TCS SP5; Leica
Microsystems CMS GmbH, Mannheim, Germany) was used to
conduct the kinetic study of Ca2+ influx in isolated acini. The main
microscopy settings were pinhole: 600 mM; argon laser: 20% of
maximum; water immersion objective:620; mode: xyt; and time
interval: 10 seconds. For each acinus, Ca2+ influx in response to
stimulation with agonists was measured with a single wavelength
excitation technique. The fluorescence of Fluo-4 AM was
measured with filters for excitation at 488 nm and for emission
at 526 nm.
During confocal microscopy, we selected the field of view which
included at least 3 acini on each slide so that they could be
analyzed at the same time. The amounts of fluorescence before
and after agonist stimulation of each selected acinus were recorded
and quantitatively analyzed by LAS AF Lite 1.8 software (Leica
Microsystems CMS GmbH).
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Ultrastructural study
Small pieces of biopsy samples were fixed with 5% glutaralde-
hyde in 0.1 M cacodylate buffer for 1 hour, postfixed in 1% OsO4
for 2 hours at 4uC, dehydrated, and embedded in epoxy resin.
The ultrathin sections were stained with uranyl acetate and lead
citrate and examined by transmission electron microscopy to
evaluate basolateral membrane alterations.
Statistics
All statistical analyses were performed using the SPSS software
program (version 16.0; IBM Corporation, Armonk, NY). When
proved to follow a normal distribution, values were expressed as
mean 6SD. The means were then compared using the two-sided
t-test for paired samples, and Least Significant Differences Test
(LSD test) was used for multiple comparisons. An a level of p,0.05
was considered statistically significant.
Results
The animals tolerated radiation well and continued to eat and
drink as usual. Mild mucositis was observed as early as when
fractions were administered for 5 days and lasted for about two
weeks. No major radiation complications were found. No
significant loss of body weight was observed.
Effect of radiation on saliva secretion function
One week after irradiation, the parotid glands in the irradiated/
sham-treated rabbits displayed a significant reduction of primary
uptake and of excretion fraction compared with values measured
before irradiation (p=0.01 and p=0.02, respectively). In contrast,
the glands in the irradiated/lidocaine-pretreated group displayed
no significant difference in primary uptake or excretion fraction
after irradiation (p=0.10 and p=0.33, respectively).(Figure 1) This
result indicates that radiation impairs both the primary tracer
uptake and the ejection function of the parotid glands but that
pretreatment with lidocaine protects against these effects and thus
can preserve the glands’ saliva secretion function.
Effect of radiation on saliva total protein
For both the irradiated/sham-treated and the irradiated/
lidocaine-pretreated rabbits, the two-sided paired-sample t-test
showed no significant difference between protein concentrations
before and after irradiation (p=0.86 and p=0.79, respectively)
(Figure 2). Consequently, saliva total protein secretion was not
affected 1 week after irradiation, and lidocaine did not affect this
parameter in either irradiated group.
Effects of neurotransmitter agonists on the Ca2+
dynamics of acinar secretion
After isolation the acini appeared intact (Figure 3). The MTT
assay verified the vitality of isolated acini. Alteration of fluores-
cence after neurotransmitter agonist stimulation of the selected
acini was quantitatively analyzed (Figure 4). The level of
fluorescence prior to agonist stimulation was set as 100%. After
carbachol stimulation, the mean6SD fluorescence levels in the
control, irradiated/sham-treated, and irradiated/lidocaine-pre-
treated groups were 142.2620.9%, 118.166.6%, and
138.9618.6%, respectively. LSD test showed that the irradiat-
ed/sham-treated group had significantly less fluorescence alter-
ation than the control group and the irradiated/lidocaine-
pretreated group (p=0.01 and p=0.02, respectively). The
fluorescence alterations of the control and irradiated/lidocaine-
pretreated groups did not significantly differ (p=0.69). (Figure 5)
Together, these results suggest that Ca2+ influx is attenuated in
response to carbachol in irradiated parotid acini, which indicates
impairment of intracellular muscarinic receptor-mediated signal-
ing of the acini; pretreatment with lidocaine, however, has a
radioprotective effect on the acini’s capacity of muscarinic agonist-
induced secretion.
After adrenaline stimulation, the mean6SD fluorescence levels
in the control, irradiated/sham-treated, and irradiated/lidocaine-
pretreated groups were 113.266.6%, 109.664.0%, and
111.966.8%, respectively. LSD test indicated similar fluorescence
alterations in the irradiated/sham-treated and irradiated/lido-
caine-pretreated groups when they were compared with the
control group (p=0.237 and p=0.657, respectively) (Figure 5).
These results reveal that adrenergic agonist-induced secretion was
not impaired one week after irradiation.
Effects on tissue ultrastructure
In all irradiated/sham-treated rabbits, alterations of the
basolateral membrane (thickening and irregular plump formations)
were observed. In contrast, no obvious basolateral membrane
alteration was observed in the irradiated/lidocaine-pretreated
group (Figure 6).
Figure 1. Scintigraphic results of parotid glands before and one week after irradiation. (A) Uptake index. (B) Ejection fraction.
doi:10.1371/journal.pone.0060256.g001
Radioprotective Effect of Lidocaine
PLOS ONE | www.plosone.org 3 March 2013 | Volume 8 | Issue 3 | e60256
Discussion
On the basis of our results, we conclude that lidocaine, as a
membrane stabilization agent, has a protective effect on the
capacity of muscarinic agonist-induced water secretion of acini
and hence can help preserve the secretory function of salivary
glands during radiotherapy. To our knowledge, this is the first
investigation of the radioprotective effect of lidocaine on
neurotransmitter agonist-induced secretion in irradiated salivary
glands.
Many prophylactic modalities have been suggested to increase
the tolerance of salivary gland tissue to radiation; such methods
include depletion of secretory granula by muscarinic alkaloid
pilocarpine [16], pretreatment with the free-radical scavenger
amifostine [17], increasing proliferation of acinar and intercalated
ductal cells by pilocarpine [2], and stem cell therapy to replace
damaged cells [18]; in addition, aquaporin-1 gene transfer which
led to increased fluid secretion from surviving duct cells has been
tested [19,20]. In our previous studies we found a prevailed
radioprotective effect of lidocaine compared with amifostine and
pilocarpine based on functional, immunohistochemical, and
ultrastructural investigations [1,11]. In the present study, we
further elucidated the potential pharmacological mechanism of the
radioprotective effect of the membrane-stabilizing agent lidocaine.
The muscarinic-cholinergic receptors in acinar cells mediate the
primary fluid secretory response [21]. When the agonists bind to
the muscarinic receptors, a Gq-protein-mediated activation of
plasma membrane-bound phospholipase C is elicited. As a result,
membrane-bound phosphatidylinositol 4,5-bisphosphate (PIP2) is
hydrolyzed into diacylglycerol and inositol 1,4,5-trisphosphate
(IP3). Afterwards, IP3 binds to an intracellular receptor, mobilizing
Ca2+ from internal Ca2+ stores such as endoplasmic reticulum
Figure 2. Saliva total protein concentration before and one week after irradiation.
doi:10.1371/journal.pone.0060256.g002
Figure 3. Confocal microscopic view of isolated acini loaded with Fluo-4 AM. (A) Before carbachol stimulation; (B) After carbachol
stimulation.
doi:10.1371/journal.pone.0060256.g003
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[4,21]. Thus, an increase in Ca2+ mobilization is the predominant
mechanism of primary saliva secretion in acini [4,8]. In the present
study we found that stimulation with carbachol induced an
increase in Ca2+ influx in the acini, but this carbachol-induced
influx was diminished in glands functionally impaired by
irradiation. This result is consistent with a previous investigation
of isolated individual acinar cells [4]. The most novel finding of
our study is the evidence that the radioprotective feature of
lidocaine may be due to its ability to protect carbachol-induced
Ca2+ influx in acini.
It is known that an increase in the Ca2+ concentration induces
the opening of a Ca2+ -activated anion (Cl– and HCO3
–) channel
and the water channel aquaporin-5 in the apical membrane as well
as a K+ channel and a Na+/K+/2Cl– cotransporter in the
basolateral membrane [21]. Ultimately, the binding of agonists to
receptors leads to secretion of isotonic primary saliva. 99mTcO4
used as a radiotracer in our study shares the Na+/K+/2Cl–
Figure 4. Confocal microscopic study of fluorescence alteration before and after carbachol stimulation of the acini. (A-C) Rabbit No. 3
in the control group; (D-F) Rabbit No. 3 in the irradiated/sham-treated group. (G-I) Rabbit No. 3 in the irradiated/lidocaine-pretreated group. (A, D and
G) Laser scanning confocal microscopic views of regions of interest before stimulation. (B, E and H) Laser scanning confocal microscopic views of
regions of interest after stimulation. (C, F and I) Quantitative dynamic analysis of fluorescence. Cch: carbachol.
doi:10.1371/journal.pone.0060256.g004
Radioprotective Effect of Lidocaine
PLOS ONE | www.plosone.org 5 March 2013 | Volume 8 | Issue 3 | e60256
cotransporter localized to the basolateral acinar cell membrane
[22], which consequently affects the initial tracer uptake of salivary
glands. This relationship explains both our scintigraphic results
after irradiation and the radioprotective effect of the membrane
stabilization agent lidocaine [11]. As a consequence of the
intracellular signaling and secretion, our scintigraphic results
verified that radiation induced damage of the acini’s water
secretion ability and that lidocaine prevented this impairment.
This conclusion was also supported by our ultrastructural findings
of damage to the basolateral cell membrane, a key site for
radiation-induced damage of the Na+/K+/2Cl– cotransporter.
Lidocaine’s cell membrane stabilization may therefore explain its
radioprotective effect on saliva secretion.
Interestingly, saliva total protein concentration was not affected
by radiation in our study. The result is in accordance with previous
studies and leakage of serum proteins into saliva is one possible
explanation. [23,24]Whereas most water secretion occurs subse-
quent to muscarinic receptor activation, protein secretion follows
b-adrenergic receptor activation. b-adrenergic receptor activation
induces a Gs-protein-mediated cyclic-AMP signal, which evokes
protein secretion in a dose-dependent manner [21]. According to a
four-phase pattern of radiation-induced damage, in phase one
(within 10 days after irradiation), alteration of the plasma
membrane interferes with activation of the muscarinic receptor,
with Gq-protein, or with both but does not impair interactions
with the b-adrenergic receptor and the Gs-protein [4,8,9]. Our
findings not only are consistent with this hypothesis but also
confirm the crucial role of this pathway as a potential target of
radioprotection. Our data also verified the fact that in the early
stage after irradiation, water secretion is specifically and severely
damaged whereas protein alteration remains negligible [4,9].
Based on the serum level curve of lidocaine reported in our
previous study[1], we used systemic delivery of lidocaine in the
present study because it was feasible to choose the optimal dose
and application time point. However one question raised by our
results is whether the systemic application of lidocaine will also
protect tumors from radiation. Although we have not investigated
this issue yet, previous studies showed that the membrane-binding
agents provide cell protection under the normoxic conditions that
dominate in normal salivary gland tissue but sensitize cells to
radiation under the hypoxic conditions found in solid head and
neck tumors [25]. Furthermore, the selective radioprotection of
muscarinic agonist-induced water secretion elucidated in the
present study also suggests that this drug is safe. Anyway, in the
future studies, local delivery of lidocaine through salivary ducts
would be more desirable for the possible translation to clinical
application.
There are several limitations in the present study to be
addressed. First, we only investigated the radioprotective effect
of lidocaine in early-stage damage. Based on our previous studies,
we chose one week after radiation as the study time-point, which
can provide comparable histopathological changes that indicate
the overall course of functional changes of salivary glands through
one month after radiation[11,26]. However the late-stage effects
are attributed by lack of repopulation from radiation induced
ductal progenitor cells damage[2]. Whether the radioprotection of
muscarinic agonist-induced water secretion by lidocaine plays a
role in the long-term aspect still needs to be revealed by an
alternative research design in future studies. Second, although our
study revealed the protective effect of lidocaine on the muscarinic
agonist-induced water secretion in irradiated salivary glands, there
are still a couple of issues to be addressed to further explore the
exact mechanisms, including the involvement of the muscarinic
receptor axis in the radioprotective profile, and the effect of
Figure 5. Fluorescence after neurotransmitter agonist stimula-
tion. The level of fluorescence prior to agonist stimulation was set as
100%. * indicates significant change when compared to other two
groups.
doi:10.1371/journal.pone.0060256.g005
Figure 6. Effects on tissue ultrastructure examined by transmission electron microscopy. (A) Normal basolateral membrane in the control
group (arrow). (B) In the irradiated/sham-treated group, thickening and irregular plump formations of basolateral membrane were observed (arrow).
(C) In the irradiated/lidocaine-pretreated group, no obvious basolateral membrane alteration was observed (arrow).
doi:10.1371/journal.pone.0060256.g006
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lidocaine on microvasculature and innervations of the glands.
These future investigations will lead us to better understand the
pharmacological mechanism of lidocaine at cellular and molecular
level.
Conclusions
In summary, the in vivo and in vitro studies presented here
demonstrate that impairment of the intracellular signal transduc-
tion induced by binding of muscarinic agonists and membrane
receptors is an essential mechanism of early-stage radiogenic
salivary gland dysfunction. Furthermore, for the first time, we have
provided evidence of the radioprotective effect of lidocaine on
salivary gland cells’ capacity for muscarinic agonist-induced water
secretion, which may explain the protection profile of lidocaine on
salivary glands during irradiation.
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